Clinical Trial Update: Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment [Phase 1, Phase 2]

View source ↗

Summary

This document describes a Phase 1/2 clinical trial assessing whether LEAP2 influences eating behavior during semaglutide treatment for obesity. The study is spo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• LEAP2 (LEAP2)
• semaglutide (semaglutide)

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Obesity &Amp; Overweight | Phase 1, Phase 2 | Status: RECRUITING